Current state of knowledge about spironolactone-induded gynecomastia. Review 2024

• Main Authors: Oliwia Kamila Iszczuk (Author), Julia Silldorff (Author), Tomasz Fura (Author), Marcin Dudek (Author), Radosław Zaucha (Author), Magdalena Gajkiewicz (Author), Zuzanna Felińska (Author), Małgorzata Zając (Author), Stanisław Anczyk (Author)
• Format: Book
• Published: Nicolaus Copernicus University in Toruń, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Spironolactone, a potassium-sparing diuretic, acts as an aldosterone antagonist but also has anti-androgen properties, leading to increased estrogen levels in the body. It can cause gynecomastia in men by blocking the production of androgens, preventing androgens from binding to specific receptors,...